|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross margin | |||||
| Selling, general and administrative expenses | |||||
| U.K. goodwill impairment | |||||
| U.K. long-lived and intangible asset impairment | |||||
| Asset impairment | |||||
| U.K. operations restructuring | |||||
| Acquisition and integration costs | |||||
| Other operating—net | |||||
| Total other operating costs and expenses | |||||
| Equity in earnings (loss) of operating affiliate | |||||
| Operating earnings | |||||
| Interest expense | |||||
| Interest income | |||||
| Loss on debt extinguishment | |||||
| Other non-operating—net | |||||
| Earnings before income taxes | |||||
| Income tax provision | |||||
| Net earnings | |||||
| Less: Net earnings attributable to noncontrolling interests | |||||
| Net earnings attributable to common stockholders | |||||
| Net earnings per share attributable to common stockholders: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted-average common shares outstanding: | |||||
| Basic | |||||
| Diluted |
Loading...
